Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials

SIMPLE SUMMARY: Lung cancer treatment has dramatically evolved in the past decade, but some pitfalls of image interpretation have been introduced in parallel, such as pseudo-progressions. These challenges could be made more evident with blinded independent central reviews, as readers are often blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaumont, Hubert, Iannessi, Antoine, Wang, Yi, Voyton, Charles M., Cillario, Jennifer, Liu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465869/
https://www.ncbi.nlm.nih.gov/pubmed/34572761
http://dx.doi.org/10.3390/cancers13184533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465869/
https://www.ncbi.nlm.nih.gov/pubmed/34572761
http://dx.doi.org/10.3390/cancers13184533

Ejemplares similares